94610 Intrapulm surfactant admn
Also known as: surfactant administration, pulmonary surfactant inhalation, neonatal surfactant
Intrapulmonary administration of exogenous surfactant by inhalation for respiratory distress syndrome in neonates and infants.
Clinical Context
Used to treat respiratory distress syndrome in premature infants by replacing deficient natural lung surfactant to improve lung compliance.
RVU Breakdown
| Work RVU | 1.13 |
| Practice Expense RVU | 0.23 |
| Malpractice RVU | 0.07 |
| Total RVU | 1.43 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.